{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/urticaria/diagnosis/investigations/","result":{"pageContext":{"chapter":{"id":"e2100cac-0eb7-55e6-b138-9cbc110f1b71","slug":"investigations","fullItemName":"Investigations","depth":2,"htmlHeader":"<!-- begin field a379141d-21e6-46e4-b106-a73200db25f8 --><h2>Which investigations should I consider?</h2><!-- end field a379141d-21e6-46e4-b106-a73200db25f8 -->","summary":"","htmlStringContent":"<!-- begin item 1a79c2e1-24bf-4c6c-8516-a73200db236a --><!-- begin field f8b7dfc1-5959-4691-937b-a73200db25f8 --><ul><li><strong>Investigations are not usually required for the diagnosis of urticaria.</strong> Consider the following investigations, if indicated after a thorough <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/diagnosis/\">history and examination</a>, to identify treatable associated conditions, identify trigger factors, or exclude <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/differential-diagnosis/\">differential diagnoses</a>:<ul><li><strong>Liver function tests (LFTs) </strong>— include viral hepatitis screen if transaminases are abnormal.</li><li><strong>Thyroid function tests (TFTs) </strong>— the presence of thyroid autoantibodies is associated with chronic urticaria in both children and adults and suggests a diagnosis of autoimmune urticaria. There is evidence that people with urticaria are more likely to have thyroid autoimmunity than people without urticaria.</li><li><strong>Erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) </strong>— an elevated ESR and/or CRP suggests an underlying systemic condition, such as chronic infection or vasculitis, and a high ESR with normal CRP may indicate paraproteinaemia.</li><li><strong>Full blood count (FBC) </strong>— eosinophil count may be elevated in parasitic infections and in some drug-induced reactions.  An elevated neutrophil count may be associated with <a class=\"topic-reference internal-reference\" href=\"/topics/urticaria/diagnosis/differential-diagnosis/\">urticarial vasculitis</a>.</li><li><em><strong>Helicobacter pylori</strong></em> testing (if gastrointestinal symptoms are present) — there is some evidence that <em>H. pylori</em> infection is significantly, though weakly, associated with an increased risk of chronic urticaria.</li><li><strong>Allergy testing </strong>— this may include patch testing or skin prick testing for suspected contact urticarias, or immunoglobulin E (IgE) tests for specific allergens.<ul><li>The diagnosis of immunological chronic urticaria is based on the clinical history and on a positive prick test with the suspected substance and/or measurement of specific IgE. </li></ul></li><li><strong>Elimination of suspected food or drugs:</strong><ul><li>Food allergy can usually be excluded as a cause of urticaria if there is no temporal relationship to a particular food trigger, by either ingestion or contact. Food additives rarely cause chronic urticaria. </li><li>Certain drugs (such as nonsteroidal anti-inflammatory drugs [NSAIDs]) can cause or aggravate chronic urticaria.</li></ul></li><li><strong>Skin biopsy </strong>— if there is an unusual pattern of presentation or in cases of suspected urticarial vasculitis.</li><li><strong>Urinalysis </strong>— screening for haematuria and proteinuria will help to detect the presence of urinary tract infection and renal involvement in vasculitis.</li><li><strong>Physical challenge, for example:</strong><ul><li><strong>Cold-induced urticaria</strong> can usually be diagnosed by placing an ice cube in a sealed plastic bag over the forearm for up to 10 minutes — weals will appear during rewarming of the skin.</li><li><strong>Dermographism</strong> can be confirmed by lightly scratching the skin with a firm object — weals will appear within 10 minutes.</li><li><strong>Aquagenic urticaria</strong> can be confirmed by immersing a body part into water or by placing wet towels for a few minutes onto the area of skin most affected — weals (typically 1–3 mm in size) will appear independent of temperature of the water.</li><li><strong>Cholinergic urticaria</strong> is triggered by sweating due to heat, emotion, or exercise, and can be provoked by exercising the person in a warm environment, although this is not routinely undertaken — ‘pinpoint’ weals (1–3 mm) and surrounded by large flares occur as a result of an increase in core body temperature.</li><li><strong>Delayed-pressure urticaria</strong> can be confirmed by a challenge with 15 pounds of weight suspended over the person's shoulder for 10 to 15 minutes — people with delayed-pressure urticaria experience swelling (which might be painful) with a delay of 4–6 hours (in some cases 12 or 24 hours) after exposure of the skin to a pressure stimulus. </li></ul></li></ul></li></ul><!-- end field f8b7dfc1-5959-4691-937b-a73200db25f8 --><!-- end item 1a79c2e1-24bf-4c6c-8516-a73200db236a -->","topic":{"id":"bfdbbcbf-5a56-51b8-b0aa-78a059b4cfec","topicId":"73ccd3ba-b5a5-4a3c-98b2-d838dd8a3c58","topicName":"Urticaria","slug":"urticaria","lastRevised":"Last revised in March 2020","chapters":[{"id":"7068e840-7bdb-5596-a56f-1c930bd4b8c4","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d6e4cfbd-5e36-5755-a780-8091e4b5f146","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9dde1c08-758f-55bb-b187-0203ded94048","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3daa7b54-d234-587b-8a56-1bb5cae1efe4","slug":"changes","fullItemName":"Changes"},{"id":"54c42276-0c06-5c18-825f-3c440cb30dfe","slug":"update","fullItemName":"Update"}]},{"id":"5cff12c3-445b-5613-bf5d-dc48effe6502","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"9abed54c-a9ed-58d4-bfce-3f0dddd49698","slug":"goals","fullItemName":"Goals"},{"id":"c2f713b4-e2ec-5e5e-be8f-5c4285be0b6e","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"e829abf6-8412-500f-9425-647958addf97","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"92b040fe-6318-560a-9ae0-6f98a6aa9c09","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"2d2f38df-88c4-5895-915d-199eefc9b02a","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d51180cd-461f-58ad-8f03-20d63965abfb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"a7fce165-b445-5aa6-9ec9-6ec8016f4bee","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a5d17f35-ddfe-5931-bfe4-b7dc039baea0","slug":"definition","fullItemName":"Definition"},{"id":"90888c1e-cd37-5fdf-9d0d-b71e51bf56c3","slug":"causes-trigger-factors","fullItemName":"Causes/trigger factors"},{"id":"76d2cc5e-4a3e-5032-8eed-d4010ace1ae7","slug":"prevalence","fullItemName":"Prevalence"},{"id":"507a6931-af71-54ae-a8e7-2b4393c2a41b","slug":"complications","fullItemName":"Complications"},{"id":"091f4740-5801-5ac0-83bd-a7ebbc2a2848","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"fc3a9cf3-3dd4-5456-94e1-90c38c83a0b1","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"513fb45b-36c0-59b5-8f88-13b10509caee","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"e2100cac-0eb7-55e6-b138-9cbc110f1b71","slug":"investigations","fullItemName":"Investigations"},{"id":"2da7bf77-7798-5632-97d4-64d5463f8cde","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1a1cabda-9d82-5131-8852-db2d844e0b46","fullItemName":"Management","slug":"management","subChapters":[{"id":"f797a7bd-9ca9-523b-8f1e-e2afc927c4ab","slug":"managing-urticaria","fullItemName":"Scenario: Managing urticaria"}]},{"id":"3c7854e6-2fe5-5632-9b63-69f2773b7dd1","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"71f6ce5f-ac94-5ef4-9a02-0aa362883a44","slug":"non-sedating-antihistamines","fullItemName":"Non-sedating antihistamines"},{"id":"8888f0f6-7dd8-55fb-afc0-9e5df55b825a","slug":"sedating-antihistamines","fullItemName":"Sedating antihistamines"},{"id":"b8336773-e3de-5ec0-a85b-93fd72ff7869","slug":"oral-corticosteroids","fullItemName":"Oral corticosteroids"}]},{"id":"c88fe5a9-a559-5661-9a1f-e0ee93078a4d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e9950b4f-8af1-5d4b-b531-431ac4a731bb","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"729aa2a2-070b-51ed-9ecf-c29549914b66","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a30a2a17-7629-5022-a313-848d8264fb35","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"f6d1c75a-6a3d-5326-97ca-baff36370740","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"dd5a897e-e7d5-5c98-88b6-35014f9a5dde","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"6d27a969-ded2-5d9d-9321-f65e47426edf","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"0d45859d-1b50-538f-84fa-568f43b5c283","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"fc3a9cf3-3dd4-5456-94e1-90c38c83a0b1","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"a91ce1e1-75de-5cc5-9cf4-0b06cfa5cee7","slug":"basis-for-recommendation-696","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 4f400ee7-7e5b-4db0-9ce1-a73200e01c54 --><h3>Basis for recommendation</h3><!-- end field 4f400ee7-7e5b-4db0-9ce1-a73200e01c54 -->","summary":null,"htmlStringContent":"<!-- begin item 696ca364-38b1-45f1-88a2-a73200e01a09 --><!-- begin field a6aa5893-795d-4cce-af7c-a73200e01c54 --><p>These recommendations are largely based on <em>The RCPCH care pathway for children with urticaria, angio-oedema or mastocytosis: an evidence and consensus based national approach </em>published by the Royal College of Paediatrics and Child Health (RCPCH)<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Leech, 2011</a>]; <em>The diagnosis and management of acute and chronic urticaria: 2014 update </em>published on behalf of the American Academy of Allergy, Asthma, and Immunology (AAAAI), the American College of Allergy, Asthma, and Immunology (ACAAI), and the Joint Council of Allergy, Asthma, and Immunology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>]; <em>The EAACI/GA²LEN</em><em>/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update </em>published<em> </em>by the European Academy of Allergy and Clinical Immunology (EAACI), the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF), and the World Allergy Organization (WAO) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>]; <em>BSACI guideline for the management of chronic urticaria and angioedema </em>published by the British Society for Allergy and Clinical Immunology (BSACI)<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>]; <em>The EAACI/GA<sup>2</sup>LEN/EDF/UNEV consensus guideline </em>published by the EAACI, the GA²LEN, the EDF, and the urticaria network e.V (UNEV) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Magerl, 2016</a>]; and on expert opinion in review articles on urticaria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Marzano, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].  </p><h4>Investigations</h4><ul><li>Expert opinion in guidelines and review articles is that:<ul><li>Investigations are not always necessary but may be needed (especially in people with chronic urticaria) to identify treatable associated conditions/trigger factors and to exclude other unusual conditions, such as urticarial vasculitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Marzano, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].</li><li>The need for investigation to find an underlying cause should be guided by the presentation and response to treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>].</li><li>Laboratory tests are not indicated in cases of acute urticaria, unless there are findings on history and physical examination that would indicate the lesions were atypical (for example painful, purpuric, non-blanching, palpable lesions, or lesions that leave residual pigmented skin) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].</li><li>Because acute urticaria will usually resolve spontaneously, laboratory investigations are not usually required, unless supported by the clinical history or physical examination. For people with chronic urticaria, targeted laboratory testing based on clinical suspicion is appropriate [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>].</li></ul></li><li>Based on clinical consensus, the EAACI/GA²LEN/EDF/WAO guideline strongly recommends [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>]:<ul><li>Limiting routine diagnostic measures to determining the threshold of eliciting factors in inducible urticaria subtypes.</li><li>Limited extended diagnostic measures in chronic spontaneous urticaria based on the person's history.</li><li>Very limited routine diagnostic measures in people with chronic spontaneous urticaria.</li><li>Against any routine diagnostic measures in people with acute urticaria.</li></ul></li></ul><h4>Specific investigations</h4><ul><li><strong><em>Helicobacter pylori </em>screening </strong><ul><li>There some evidence that prevalence of <em>H. pylori</em> infection is higher in people with urticaria than in people without.</li><li>A meta-analysis of observational studies investigated the association between <em>H. pylori</em> infection and chronic urticaria (n = 965 chronic urticaria cases and 1235 controls) and found that <em>H. pylori</em> infection is significantly, though weakly, associated with an increased risk of chronic urticaria [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Gu, 2015</a>].</li><li>Expert opinion in the EAACI/GA²LEN/EDF/WAO guideline is that even if association with urticaria is not clear, <em>H. pylori </em>should be eliminated as it is associated with gastric cancer [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Zuberbier, 2014</a>].</li></ul></li><li><strong>Thyroid function tests (TFTs)</strong><ul><li>There is evidence that people with urticaria are more likely to have thyroid autoimmunity than people without urticaria.</li><li>A systematic review and meta-analysis investigated the associations between thyroid autoantibodies and urticaria (n = 14,203 urticaria cases and 12,339 non-urticaria controls) and found that the prevalence of positive thyroid autoantibodies in people with urticaria was higher than for non-urticaria controls [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Pan, 2015</a>].</li></ul></li><li><strong>Allergy testing </strong><ul><li>The information on the diagnosis of immunological chronic urticaria is based on expert opinion in a systematic clinical review [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Lukacs, 2016</a>].</li><li>Expert opinion in a review article is that skin-prick testing for a broad panel of food or environmental allergens is generally ineffective and is not recommended. However, testing for a specific food or allergen based on the history is more useful and can provide greater diagnostic usefulness [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">BMJ, 2016</a>].</li><li>Expert opinion in the BSACI guideline is that the sight of negative skin prick tests will help to reassure the person that allergy is not the cause of their symptoms and may contribute to improved adherence with long-term antihistamine treatment [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>].</li></ul></li><li><strong>Elimination of suspected drugs or food</strong><ul><li>The information on when a food allergy can be excluded as a cause of urticaria is based on expert opinion in the BSACI guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>].</li></ul></li><li><strong>Physical challenge</strong><ul><li>The information on the physical challenges is based on expert opinion in the BSACI guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Powell, 2015</a>] and the joint AAAAI/ACAAI guideline<em> </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/urticaria/references/\">Bernstein, 2014</a>].</li></ul></li></ul><!-- end field a6aa5893-795d-4cce-af7c-a73200e01c54 --><!-- end item 696ca364-38b1-45f1-88a2-a73200e01a09 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}